Full Text of SB2038 100th General Assembly
SB2038sam003 100TH GENERAL ASSEMBLY | Sen. Chapin Rose Filed: 5/23/2017
| | 10000SB2038sam003 | | LRB100 11368 MJP 26165 a |
|
| 1 | | AMENDMENT TO SENATE BILL 2038
| 2 | | AMENDMENT NO. ______. Amend Senate Bill 2038, AS AMENDED, | 3 | | by replacing everything after the enacting clause with the | 4 | | following:
| 5 | | "Section 1. Short title. This Act may be cited as the | 6 | | Epinephrine Administration Act.
| 7 | | Section 5. Definitions. As used in this Act: | 8 | | "Authorized entity" means any entity or organization, | 9 | | other than a school covered under Section 22-30 of the School | 10 | | Code, in connection with or at which allergens capable of | 11 | | causing anaphylaxis may be present, including, but not limited | 12 | | to, independent contractors who provide student transportation | 13 | | to schools, recreation camps, colleges and universities, day | 14 | | care facilities, youth sports leagues, amusement parks, | 15 | | restaurants, sports arenas, and places of employment. The | 16 | | Department shall, by rule, determine what constitutes a day |
| | | 10000SB2038sam003 | - 2 - | LRB100 11368 MJP 26165 a |
|
| 1 | | care facility under this definition. | 2 | | "Department" means the Department of Public Health. | 3 | | "Epinephrine pre-filled syringe" means a pre-filled | 4 | | syringe of epinephrine used for the administration of a | 5 | | pre-measured dose of epinephrine into the human body that is | 6 | | equivalent to the dosages used in an auto-injector. | 7 | | "Health care practitioner" means a physician licensed to | 8 | | practice medicine in all its branches under the Medical | 9 | | Practice Act of 1987, a physician assistant under the Physician | 10 | | Assistant Practice Act of 1987 with prescriptive authority, or | 11 | | an advanced practice nurse with prescribing authority under | 12 | | Article 65 of the Nurse Practice Act. | 13 | | "Pharmacist" has the meaning given to that term under | 14 | | subsection (k-5) of Section 3 of the Pharmacy Practice Act. | 15 | | "Undesignated epinephrine pre-filled syringe" means an | 16 | | epinephrine pre-filled syringe prescribed in the name of an | 17 | | authorized entity.
| 18 | | Section 10. Prescription to authorized entity; use; | 19 | | training. | 20 | | (a) A health care practitioner may prescribe epinephrine | 21 | | pre-filled syringes in the name of an authorized entity for use | 22 | | in accordance with this Act, and pharmacists may dispense | 23 | | epinephrine pre-filled syringes in accordance with a | 24 | | prescription issued in the name of an authorized entity. Such | 25 | | prescriptions shall be valid for a period of 2 years. |
| | | 10000SB2038sam003 | - 3 - | LRB100 11368 MJP 26165 a |
|
| 1 | | (b) An authorized entity may acquire and stock a supply of | 2 | | undesignated epinephrine pre-filled syringes in accordance | 3 | | with a prescription issued under subsection (a) of this | 4 | | Section. Such undesignated epinephrine pre-filled syringes | 5 | | shall be stored in a location readily accessible in an | 6 | | emergency and in accordance with the instructions for use of | 7 | | the epinephrine pre-filled syringes. The Department may | 8 | | establish any additional requirements an authorized entity | 9 | | must follow under this Act. | 10 | | (c) An employee or agent of an authorized entity or other | 11 | | individual who has completed training under subsection (d) of | 12 | | this Section may: | 13 | | (1) provide an epinephrine pre-filled syringe to any | 14 | | individual on the property of the authorized entity whom | 15 | | the employee, agent, or other individual believes in good | 16 | | faith is experiencing anaphylaxis, or to the parent, | 17 | | guardian, or caregiver of such individual, for immediate | 18 | | administration, regardless of whether the individual has a | 19 | | prescription for an epinephrine pre-filled syringe or has | 20 | | previously been diagnosed with an allergy; or | 21 | | (2) administer epinephrine from a pre-filled syringe | 22 | | to any individual on the property of the authorized entity | 23 | | whom the employee, agent, or other individual believes in | 24 | | good faith is experiencing anaphylaxis, regardless of | 25 | | whether the individual has a prescription for an | 26 | | epinephrine pre-filled syringe or has previously been |
| | | 10000SB2038sam003 | - 4 - | LRB100 11368 MJP 26165 a |
|
| 1 | | diagnosed with an allergy. | 2 | | The employee or agent of an authorized entity or other | 3 | | individual under this subsection must be at least 18 years old | 4 | | to provide an epinephrine pre-filled syringe or administer | 5 | | epinephrine from a pre-filled syringe under this subsection. | 6 | | (d) An employee, agent, or other individual authorized must | 7 | | complete an anaphylaxis training program before he or she is | 8 | | able to provide or administer epinephrine from a pre-filled | 9 | | syringe under this Section. Such training shall be valid for a | 10 | | period of 2 years and shall be conducted by a nationally | 11 | | recognized organization experienced in training laypersons in | 12 | | emergency health treatment. The Department shall include links | 13 | | to training providers' websites on its website. | 14 | | Training shall include, but is not limited to: | 15 | | (1) how to recognize signs and symptoms of an allergic | 16 | | reaction, including anaphylaxis; | 17 | | (2) how to administer epinephrine from a pre-filled | 18 | | syringe; and | 19 | | (3) a test demonstrating competency of the knowledge | 20 | | required to recognize anaphylaxis and administer | 21 | | epinephrine from a pre-filled syringe. | 22 | | Training may also include, but is not limited to: | 23 | | (A) a review of high-risk areas on the authorized | 24 | | entity's property and its related facilities; | 25 | | (B) steps to take to prevent exposure to allergens; | 26 | | (C) emergency follow-up procedures; and |
| | | 10000SB2038sam003 | - 5 - | LRB100 11368 MJP 26165 a |
|
| 1 | | (D) other criteria as determined in rules adopted | 2 | | pursuant to this Act. | 3 | | Training may be conducted either online or in person. The | 4 | | Department shall approve training programs and list permitted | 5 | | training programs on the Department's Internet website. | 6 | | (e) A health care practitioner providing a prescription for | 7 | | epinephrine in accordance with this Act shall incur no | 8 | | liability or professional discipline, except for willful and | 9 | | wanton misconduct, as a result of any injury arising from the | 10 | | use of epinephrine under this Act. | 11 | | Section 15. Costs. Whichever entity initiates the process | 12 | | of obtaining undesignated epinephrine pre-filled syringes and | 13 | | providing training to personnel for carrying and administering | 14 | | epinephrine from undesignated epinephrine pre-filled syringes | 15 | | shall pay for the costs of the undesignated epinephrine | 16 | | pre-filled syringes.
| 17 | | Section 20. Limitations. The use of an undesignated | 18 | | epinephrine pre-filled syringe in accordance with the | 19 | | requirements of this Act does not constitute the practice of | 20 | | medicine or any other profession that requires medical | 21 | | licensure. | 22 | | Nothing in this Act shall limit the amount of epinephrine | 23 | | pre-filled syringes that an authorized entity or individual may | 24 | | carry or maintain a supply of.
|
| | | 10000SB2038sam003 | - 6 - | LRB100 11368 MJP 26165 a |
|
| 1 | | Section 85. Rulemaking. The Department shall adopt any | 2 | | rules necessary to implement and administer this Act.
| 3 | | Section 90. The School Code is amended by changing Section | 4 | | 22-30 as follows:
| 5 | | (105 ILCS 5/22-30)
| 6 | | Sec. 22-30. Self-administration and self-carry of asthma | 7 | | medication and epinephrine injectors auto-injectors ; | 8 | | administration of undesignated epinephrine injectors | 9 | | auto-injectors ; administration of an opioid antagonist; asthma | 10 | | episode emergency response protocol.
| 11 | | (a) For the purpose of this Section only, the following | 12 | | terms shall have the meanings set forth below:
| 13 | | "Asthma action plan" means a written plan developed with a | 14 | | pupil's medical provider to help control the pupil's asthma. | 15 | | The goal of an asthma action plan is to reduce or prevent | 16 | | flare-ups and emergency department visits through day-to-day | 17 | | management and to serve as a student-specific document to be | 18 | | referenced in the event of an asthma episode. | 19 | | "Asthma episode emergency response protocol" means a | 20 | | procedure to provide assistance to a pupil experiencing | 21 | | symptoms of wheezing, coughing, shortness of breath, chest | 22 | | tightness, or breathing difficulty. | 23 | | "Asthma inhaler" means a quick reliever asthma inhaler. |
| | | 10000SB2038sam003 | - 7 - | LRB100 11368 MJP 26165 a |
|
| 1 | | "Epinephrine auto-injector" means a single-use device used | 2 | | for the automatic injection of a pre-measured dose of | 3 | | epinephrine into the human body.
| 4 | | "Epinephrine injector" includes an auto-injector for the | 5 | | administration of epinephrine or a pre-filled syringe used for | 6 | | the administration of epinephrine that contain a pre-measured | 7 | | dose of epinephrine that is equivalent to the dosages used in | 8 | | an auto-injector. | 9 | | "Asthma medication" means a medicine, prescribed by (i) a | 10 | | physician
licensed to practice medicine in all its branches,
| 11 | | (ii) a licensed physician assistant with prescriptive | 12 | | authority , or (iii) a licensed advanced practice
nurse with | 13 | | prescriptive authority
for a pupil that pertains to the pupil's
| 14 | | asthma and that has an individual prescription label.
| 15 | | "Opioid antagonist" means a drug that binds to opioid | 16 | | receptors and blocks or inhibits the effect of opioids acting | 17 | | on those receptors, including, but not limited to, naloxone | 18 | | hydrochloride or any other similarly acting drug approved by | 19 | | the U.S. Food and Drug Administration. | 20 | | "School nurse" means a registered nurse working in a school | 21 | | with or without licensure endorsed in school nursing. | 22 | | "Self-administration" means a pupil's discretionary use of | 23 | | his or
her prescribed asthma medication or epinephrine injector | 24 | | auto-injector .
| 25 | | "Self-carry" means a pupil's ability to carry his or her | 26 | | prescribed asthma medication or epinephrine injector |
| | | 10000SB2038sam003 | - 8 - | LRB100 11368 MJP 26165 a |
|
| 1 | | auto-injector . | 2 | | "Standing protocol" may be issued by (i) a physician | 3 | | licensed to practice medicine in all its branches, (ii) a | 4 | | licensed physician assistant with prescriptive authority , or | 5 | | (iii) a licensed advanced practice nurse with prescriptive | 6 | | authority. | 7 | | "Trained personnel" means any school employee or volunteer | 8 | | personnel authorized in Sections 10-22.34, 10-22.34a, and | 9 | | 10-22.34b of this Code who has completed training under | 10 | | subsection (g) of this Section to recognize and respond to | 11 | | anaphylaxis. | 12 | | "Undesignated epinephrine injector auto-injector " means an | 13 | | epinephrine injector auto-injector prescribed in the name of a | 14 | | school district, public school, or nonpublic school. | 15 | | (b) A school, whether public or nonpublic, must permit the
| 16 | | self-administration and self-carry of asthma
medication by a | 17 | | pupil with asthma or the self-administration and self-carry of | 18 | | an epinephrine injector auto-injector by a pupil, provided | 19 | | that:
| 20 | | (1) the parents or
guardians of the pupil provide to | 21 | | the school (i) written
authorization from the parents or | 22 | | guardians for (A) the self-administration and self-carry | 23 | | of asthma medication or (B) the self-carry of asthma | 24 | | medication or (ii) for (A) the self-administration and | 25 | | self-carry of an epinephrine injector auto-injector or (B) | 26 | | the self-carry of an epinephrine injector auto-injector , |
| | | 10000SB2038sam003 | - 9 - | LRB100 11368 MJP 26165 a |
|
| 1 | | written authorization from the pupil's physician, | 2 | | physician assistant, or advanced practice nurse; and
| 3 | | (2) the
parents or guardians of the pupil provide to | 4 | | the school (i) the prescription label, which must contain | 5 | | the name of the asthma medication, the prescribed dosage, | 6 | | and the time at which or circumstances under which the | 7 | | asthma medication is to be administered, or (ii) for the | 8 | | self-administration or self-carry of an epinephrine | 9 | | injector auto-injector , a
written
statement from the | 10 | | pupil's physician, physician assistant, or advanced | 11 | | practice
nurse containing
the following information:
| 12 | | (A) the name and purpose of the epinephrine | 13 | | injector auto-injector ;
| 14 | | (B) the prescribed dosage; and
| 15 | | (C) the time or times at which or the special | 16 | | circumstances
under which the epinephrine injector | 17 | | auto-injector is to be administered.
| 18 | | The information provided shall be kept on file in the office of | 19 | | the school
nurse or,
in the absence of a school nurse, the | 20 | | school's administrator.
| 21 | | (b-5) A school district, public school, or nonpublic school | 22 | | may authorize the provision of a student-specific or | 23 | | undesignated epinephrine injector auto-injector to a student | 24 | | or any personnel authorized under a student's Individual Health | 25 | | Care Action Plan, Illinois Food Allergy Emergency Action Plan | 26 | | and Treatment Authorization Form, or plan pursuant to Section |
| | | 10000SB2038sam003 | - 10 - | LRB100 11368 MJP 26165 a |
|
| 1 | | 504 of the federal Rehabilitation Act of 1973 to administer an | 2 | | epinephrine injector auto-injector to the student, that meets | 3 | | the student's prescription on file. | 4 | | (b-10) The school district, public school, or nonpublic | 5 | | school may authorize a school nurse or trained personnel to do | 6 | | the following: (i) provide an undesignated epinephrine | 7 | | injector auto-injector to a student for self-administration | 8 | | only or any personnel authorized under a student's Individual | 9 | | Health Care Action Plan, Illinois Food Allergy Emergency Action | 10 | | Plan and Treatment Authorization Form, or plan pursuant to | 11 | | Section 504 of the federal Rehabilitation Act of 1973 to | 12 | | administer to the student, that meets the student's | 13 | | prescription on file; (ii) administer an undesignated | 14 | | epinephrine injector auto-injector that meets the prescription | 15 | | on file to any student who has an Individual Health Care Action | 16 | | Plan, Illinois Food Allergy Emergency Action Plan and Treatment | 17 | | Authorization Form, or plan pursuant to Section 504 of the | 18 | | federal Rehabilitation Act of 1973 that authorizes the use of | 19 | | an epinephrine injector auto-injector ; (iii) administer an | 20 | | undesignated epinephrine injector auto-injector to any person | 21 | | that the school nurse or trained personnel in good faith | 22 | | believes is having an anaphylactic reaction; and (iv) | 23 | | administer an opioid antagonist to any person that the school | 24 | | nurse or trained personnel in good faith believes is having an | 25 | | opioid overdose. | 26 | | (c) The school district, public school, or nonpublic school |
| | | 10000SB2038sam003 | - 11 - | LRB100 11368 MJP 26165 a |
|
| 1 | | must inform the parents or
guardians of the
pupil, in writing, | 2 | | that the school district, public school, or nonpublic school | 3 | | and its
employees and
agents, including a physician, physician | 4 | | assistant, or advanced practice nurse providing standing | 5 | | protocol or prescription for school epinephrine injectors | 6 | | auto-injectors ,
are to incur no liability or professional | 7 | | discipline, except for willful and wanton conduct, as a result
| 8 | | of any injury arising from the
administration of asthma | 9 | | medication, an epinephrine injector auto-injector , or an | 10 | | opioid antagonist regardless of whether authorization was | 11 | | given by the pupil's parents or guardians or by the pupil's | 12 | | physician, physician assistant, or advanced practice nurse. | 13 | | The parents or guardians
of the pupil must sign a statement | 14 | | acknowledging that the school district, public school,
or | 15 | | nonpublic school and its employees and agents are to incur no | 16 | | liability, except for willful and wanton
conduct, as a result | 17 | | of any injury arising
from the
administration of asthma | 18 | | medication, an epinephrine injector auto-injector , or an | 19 | | opioid antagonist regardless of whether authorization was | 20 | | given by the pupil's parents or guardians or by the pupil's | 21 | | physician, physician assistant, or advanced practice nurse and | 22 | | that the parents or
guardians must indemnify and hold harmless | 23 | | the school district, public school, or nonpublic
school and
its
| 24 | | employees and agents against any claims, except a claim based | 25 | | on willful and
wanton conduct, arising out of the
| 26 | | administration of asthma medication, an epinephrine injector |
| | | 10000SB2038sam003 | - 12 - | LRB100 11368 MJP 26165 a |
|
| 1 | | auto-injector , or an opioid antagonist regardless of whether | 2 | | authorization was given by the pupil's parents or guardians or | 3 | | by the pupil's physician, physician assistant, or advanced | 4 | | practice nurse. | 5 | | (c-5) When a school nurse or trained personnel administers | 6 | | an undesignated epinephrine injector auto-injector to a person | 7 | | whom the school nurse or trained personnel in good faith | 8 | | believes is having an anaphylactic reaction or administers an | 9 | | opioid antagonist to a person whom the school nurse or trained | 10 | | personnel in good faith believes is having an opioid overdose, | 11 | | notwithstanding the lack of notice to the parents or guardians | 12 | | of the pupil or the absence of the parents or guardians signed | 13 | | statement acknowledging no liability, except for willful and | 14 | | wanton conduct, the school district, public school, or | 15 | | nonpublic school and its employees and agents, and a physician, | 16 | | a physician assistant, or an advanced practice nurse providing | 17 | | standing protocol or prescription for undesignated epinephrine | 18 | | injectors auto-injectors , are to incur no liability or | 19 | | professional discipline, except for willful and wanton | 20 | | conduct, as a result of any injury arising from the use of an | 21 | | undesignated epinephrine injector auto-injector or the use of | 22 | | an opioid antagonist regardless of whether authorization was | 23 | | given by the pupil's parents or guardians or by the pupil's | 24 | | physician, physician assistant, or advanced practice nurse.
| 25 | | (d) The permission for self-administration and self-carry | 26 | | of asthma medication or the self-administration and self-carry |
| | | 10000SB2038sam003 | - 13 - | LRB100 11368 MJP 26165 a |
|
| 1 | | of an epinephrine injector auto-injector is effective
for the | 2 | | school year for which it is granted and shall be renewed each
| 3 | | subsequent school year upon fulfillment of the requirements of | 4 | | this
Section.
| 5 | | (e) Provided that the requirements of this Section are | 6 | | fulfilled, a
pupil with asthma may self-administer and | 7 | | self-carry his or her asthma medication or a pupil may | 8 | | self-administer and self-carry an epinephrine injector | 9 | | auto-injector (i) while in
school, (ii) while at a | 10 | | school-sponsored activity, (iii) while under the
supervision | 11 | | of
school personnel, or (iv) before or after normal school | 12 | | activities, such
as while in before-school or after-school care | 13 | | on school-operated
property or while being transported on a | 14 | | school bus.
| 15 | | (e-5) Provided that the requirements of this Section are | 16 | | fulfilled, a school nurse or trained personnel may administer | 17 | | an undesignated epinephrine injector auto-injector to any | 18 | | person whom the school nurse or trained personnel in good faith | 19 | | believes to be having an anaphylactic reaction (i) while in | 20 | | school, (ii) while at a school-sponsored activity, (iii) while | 21 | | under the supervision of school personnel, or (iv) before or | 22 | | after normal school activities, such
as while in before-school | 23 | | or after-school care on school-operated property or while being | 24 | | transported on a school bus. A school nurse or trained | 25 | | personnel may carry undesignated epinephrine injectors | 26 | | auto-injectors on his or her person while in school or at a |
| | | 10000SB2038sam003 | - 14 - | LRB100 11368 MJP 26165 a |
|
| 1 | | school-sponsored activity. | 2 | | (e-10) Provided that the requirements of this Section are | 3 | | fulfilled, a school nurse or trained personnel may administer | 4 | | an opioid antagonist to any person whom the school nurse or | 5 | | trained personnel in good faith believes to be having an opioid | 6 | | overdose (i) while in school, (ii) while at a school-sponsored | 7 | | activity, (iii) while under the supervision of school | 8 | | personnel, or (iv) before or after normal school activities, | 9 | | such as while in before-school or after-school care on | 10 | | school-operated property. A school nurse or trained personnel | 11 | | may carry an opioid antagonist on their person while in school | 12 | | or at a school-sponsored activity. | 13 | | (f) The school district, public school, or nonpublic school | 14 | | may maintain a supply of undesignated epinephrine injectors | 15 | | auto-injectors in any secure location that is accessible | 16 | | before, during, and after school where an allergic person is | 17 | | most at risk, including, but not limited to, classrooms and | 18 | | lunchrooms. A physician, a physician assistant who has been | 19 | | delegated prescriptive authority in accordance with Section | 20 | | 7.5 of the Physician Assistant Practice Act of 1987, or an | 21 | | advanced practice nurse who has been delegated prescriptive | 22 | | authority in accordance with Section 65-40 of the Nurse | 23 | | Practice Act may prescribe undesignated epinephrine injectors | 24 | | auto-injectors in the name of the school district, public | 25 | | school, or nonpublic school to be maintained for use when | 26 | | necessary. Any supply of epinephrine injectors auto-injectors |
| | | 10000SB2038sam003 | - 15 - | LRB100 11368 MJP 26165 a |
|
| 1 | | shall be maintained in accordance with the manufacturer's | 2 | | instructions. | 3 | | The school district, public school, or nonpublic school may | 4 | | maintain a supply of an opioid antagonist in any secure | 5 | | location where an individual may have an opioid overdose. A | 6 | | health care professional who has been delegated prescriptive | 7 | | authority for opioid antagonists in accordance with Section | 8 | | 5-23 of the Alcoholism and Other Drug Abuse and Dependency Act | 9 | | may prescribe opioid antagonists in the name of the school | 10 | | district, public school, or nonpublic school, to be maintained | 11 | | for use when necessary. Any supply of opioid antagonists shall | 12 | | be maintained in accordance with the manufacturer's | 13 | | instructions. | 14 | | (f-3) Whichever entity initiates the process of obtaining | 15 | | undesignated epinephrine injectors auto-injectors and | 16 | | providing training to personnel for carrying and administering | 17 | | undesignated epinephrine injectors auto-injectors shall pay | 18 | | for the costs of the undesignated epinephrine injectors | 19 | | auto-injectors . | 20 | | (f-5) Upon any administration of an epinephrine injector | 21 | | auto-injector , a school district, public school, or nonpublic | 22 | | school must immediately activate the EMS system and notify the | 23 | | student's parent, guardian, or emergency contact, if known. | 24 | | Upon any administration of an opioid antagonist, a school | 25 | | district, public school, or nonpublic school must immediately | 26 | | activate the EMS system and notify the student's parent, |
| | | 10000SB2038sam003 | - 16 - | LRB100 11368 MJP 26165 a |
|
| 1 | | guardian, or emergency contact, if known. | 2 | | (f-10) Within 24 hours of the administration of an | 3 | | undesignated epinephrine injector auto-injector , a school | 4 | | district, public school, or nonpublic school must notify the | 5 | | physician, physician assistant, or advanced practice nurse who | 6 | | provided the standing protocol or prescription for the | 7 | | undesignated epinephrine injector auto-injector of its use. | 8 | | Within 24 hours after the administration of an opioid | 9 | | antagonist, a school district, public school, or nonpublic | 10 | | school must notify the health care professional who provided | 11 | | the prescription for the opioid antagonist of its use. | 12 | | (g) Prior to the administration of an undesignated | 13 | | epinephrine injector auto-injector , trained personnel must | 14 | | submit to their school's administration proof of completion of | 15 | | a training curriculum to recognize and respond to anaphylaxis | 16 | | that meets the requirements of subsection (h) of this Section. | 17 | | Training must be completed annually. their The school district, | 18 | | public school, or nonpublic school must maintain records | 19 | | related to the training curriculum and trained personnel. | 20 | | Prior to the administration of an opioid antagonist, | 21 | | trained personnel must submit to their school's administration | 22 | | proof of completion of a training curriculum to recognize and | 23 | | respond to an opioid overdose, which curriculum must meet the | 24 | | requirements of subsection (h-5) of this Section. Training must | 25 | | be completed annually. Trained personnel must also submit to | 26 | | the school's administration proof of cardiopulmonary |
| | | 10000SB2038sam003 | - 17 - | LRB100 11368 MJP 26165 a |
|
| 1 | | resuscitation and automated external defibrillator | 2 | | certification. The school district, public school, or | 3 | | nonpublic school must maintain records relating to the training | 4 | | curriculum and the trained personnel. | 5 | | (h) A training curriculum to recognize and respond to | 6 | | anaphylaxis, including the administration of an undesignated | 7 | | epinephrine injector auto-injector , may be conducted online or | 8 | | in person. | 9 | | Training shall include, but is not limited to: | 10 | | (1) how to recognize signs and symptoms of an allergic | 11 | | reaction, including anaphylaxis; | 12 | | (2) how to administer an epinephrine injector | 13 | | auto-injector ; and | 14 | | (3) a test demonstrating competency of the knowledge | 15 | | required to recognize anaphylaxis and administer an | 16 | | epinephrine injector auto-injector . | 17 | | Training may also include, but is not limited to: | 18 | | (A) a review of high-risk areas within a school and its | 19 | | related facilities; | 20 | | (B) steps to take to prevent exposure to allergens; | 21 | | (C) emergency follow-up procedures; | 22 | | (D) how to respond to a student with a known allergy, | 23 | | as well as a student with a previously unknown allergy; and | 24 | | (E) other criteria as determined in rules adopted | 25 | | pursuant to this Section. | 26 | | In consultation with statewide professional organizations |
| | | 10000SB2038sam003 | - 18 - | LRB100 11368 MJP 26165 a |
|
| 1 | | representing physicians licensed to practice medicine in all of | 2 | | its branches, registered nurses, and school nurses, the State | 3 | | Board of Education shall make available resource materials | 4 | | consistent with criteria in this subsection (h) for educating | 5 | | trained personnel to recognize and respond to anaphylaxis. The | 6 | | State Board may take into consideration the curriculum on this | 7 | | subject developed by other states, as well as any other | 8 | | curricular materials suggested by medical experts and other | 9 | | groups that work on life-threatening allergy issues. The State | 10 | | Board is not required to create new resource materials. The | 11 | | State Board shall make these resource materials available on | 12 | | its Internet website. | 13 | | (h-5) A training curriculum to recognize and respond to an | 14 | | opioid overdose, including the administration of an opioid | 15 | | antagonist, may be conducted online or in person. The training | 16 | | must comply with any training requirements under Section 5-23 | 17 | | of the Alcoholism and Other Drug Abuse and Dependency Act and | 18 | | the corresponding rules. It must include, but is not limited | 19 | | to: | 20 | | (1) how to recognize symptoms of an opioid overdose; | 21 | | (2) information on drug overdose prevention and | 22 | | recognition; | 23 | | (3) how to perform rescue breathing and resuscitation; | 24 | | (4) how to respond to an emergency involving an opioid | 25 | | overdose; | 26 | | (5) opioid antagonist dosage and administration; |
| | | 10000SB2038sam003 | - 19 - | LRB100 11368 MJP 26165 a |
|
| 1 | | (6) the importance of calling 911; | 2 | | (7) care for the overdose victim after administration | 3 | | of the overdose antagonist; | 4 | | (8) a test demonstrating competency of the knowledge | 5 | | required to recognize an opioid overdose and administer a | 6 | | dose of an opioid antagonist; and | 7 | | (9) other criteria as determined in rules adopted | 8 | | pursuant to this Section. | 9 | | (i) Within 3 days after the administration of an | 10 | | undesignated epinephrine injector auto-injector by a school | 11 | | nurse, trained personnel, or a student at a school or | 12 | | school-sponsored activity, the school must report to the State | 13 | | Board of Education in a form and manner prescribed by the State | 14 | | Board the following information: | 15 | | (1) age and type of person receiving epinephrine | 16 | | (student, staff, visitor); | 17 | | (2) any previously known diagnosis of a severe allergy; | 18 | | (3) trigger that precipitated allergic episode; | 19 | | (4) location where symptoms developed; | 20 | | (5) number of doses administered; | 21 | | (6) type of person administering epinephrine (school | 22 | | nurse, trained personnel, student); and | 23 | | (7) any other information required by the State Board. | 24 | | If a school district, public school, or nonpublic school | 25 | | maintains or has an independent contractor providing | 26 | | transportation to students who maintains a supply of |
| | | 10000SB2038sam003 | - 20 - | LRB100 11368 MJP 26165 a |
|
| 1 | | undesignated epinephrine injectors auto-injectors , then the | 2 | | school district, public school, or nonpublic school must report | 3 | | that information to the State Board of Education upon adoption | 4 | | or change of the policy of the school district, public school, | 5 | | nonpublic school, or independent contractor, in a manner as | 6 | | prescribed by the State Board. The report must include the | 7 | | number of undesignated epinephrine injectors auto-injectors in | 8 | | supply. | 9 | | (i-5) Within 3 days after the administration of an opioid | 10 | | antagonist by a school nurse or trained personnel, the school | 11 | | must report to the State Board of Education , in a form and | 12 | | manner prescribed by the State Board, the following | 13 | | information: | 14 | | (1) the age and type of person receiving the opioid | 15 | | antagonist (student, staff, or visitor); | 16 | | (2) the location where symptoms developed; | 17 | | (3) the type of person administering the opioid | 18 | | antagonist (school nurse or trained personnel); and | 19 | | (4) any other information required by the State Board. | 20 | | (j) By October 1, 2015 and every year thereafter, the State | 21 | | Board of Education shall submit a report to the General | 22 | | Assembly identifying the frequency and circumstances of | 23 | | epinephrine administration during the preceding academic year. | 24 | | Beginning with the 2017 report, the report shall also contain | 25 | | information on which school districts, public schools, and | 26 | | nonpublic schools maintain or have independent contractors |
| | | 10000SB2038sam003 | - 21 - | LRB100 11368 MJP 26165 a |
|
| 1 | | providing transportation to students who maintain a supply of | 2 | | undesignated epinephrine injectors auto-injectors . This report | 3 | | shall be published on the State Board's Internet website on the | 4 | | date the report is delivered to the General Assembly. | 5 | | (j-5) Annually, each school district, public school, | 6 | | charter school, or nonpublic school shall request an asthma | 7 | | action plan from the parents or guardians of a pupil with | 8 | | asthma. If provided, the asthma action plan must be kept on | 9 | | file in the office of the school nurse or, in the absence of a | 10 | | school nurse, the school administrator. Copies of the asthma | 11 | | action plan may be distributed to appropriate school staff who | 12 | | interact with the pupil on a regular basis, and, if applicable, | 13 | | may be attached to the pupil's federal Section 504 plan or | 14 | | individualized education program plan. | 15 | | (j-10) To assist schools with emergency response | 16 | | procedures for asthma, the State Board of Education, in | 17 | | consultation with statewide professional organizations with | 18 | | expertise in asthma management and a statewide organization | 19 | | representing school administrators, shall develop a model | 20 | | asthma episode emergency response protocol before September 1, | 21 | | 2016. Each school district, charter school, and nonpublic | 22 | | school shall adopt an asthma episode emergency response | 23 | | protocol before January 1, 2017 that includes all of the | 24 | | components of the State Board's model protocol. | 25 | | (j-15) Every 2 years, school personnel who work with pupils | 26 | | shall complete an in-person or online training program on the |
| | | 10000SB2038sam003 | - 22 - | LRB100 11368 MJP 26165 a |
|
| 1 | | management of asthma, the prevention of asthma symptoms, and | 2 | | emergency response in the school setting. In consultation with | 3 | | statewide professional organizations with expertise in asthma | 4 | | management, the State Board of Education shall make available | 5 | | resource materials for educating school personnel about asthma | 6 | | and emergency response in the school setting. | 7 | | (j-20) On or before October 1, 2016 and every year | 8 | | thereafter, the State Board of Education shall submit a report | 9 | | to the General Assembly and the Department of Public Health | 10 | | identifying the frequency and circumstances of opioid | 11 | | antagonist administration during the preceding academic year. | 12 | | This report shall be published on the State Board's Internet | 13 | | website on the date the report is delivered to the General | 14 | | Assembly. | 15 | | (k) The State Board of Education may adopt rules necessary | 16 | | to implement this Section. | 17 | | (l) Nothing in this Section shall limit the amount of | 18 | | epinephrine injectors auto-injectors that any type of school or | 19 | | student may carry or maintain a supply of. | 20 | | (Source: P.A. 98-795, eff. 8-1-14; 99-173, eff. 7-29-15; | 21 | | 99-480, eff. 9-9-15; 99-642, eff. 7-28-16; 99-711, eff. 1-1-17; | 22 | | 99-843, eff. 8-19-16; revised 9-8-16.)".
|
|